Nic Lochlainn Consulting has a unique, 360 degree insight into reimbursement decision-making. Eimear Nic Lochlainn has in-depth knowledge of the pharmaceutical sector from an industry and payer perspective, the latter gained from her experience as an economic assessor and statistical advisor to the Scottish Medicines Consortium.
Eimear works directly with large and small Pharma companies, both at a global and regional level.
She also collaborates with other consultancy companies to complement their skills gaps as well as working with academic centres, P&R agencies and patient organisations.
Nic Lochlainn Consulting approaches global projects both from an industry and payer perspective balancing the evidence needs of pricing and reimbursement (P&R) agencies with the requirements of regulatory authorities to obtain regulatory approval. Eimear's approach synthesizes the need and recommendations of P&R agencies such as PBAC in Australia, CDR in Canada, HAS in France, IQWiG in Germany, CVZ in the Netherlands, TLV in Sweden and SMC/AWMSG/NICE in the UK, to inform strategic recommendations.
Eimear draws on her wealth of clinical development and reimbursement expertise to identify evidence gaps which may represent hurdles to reimbursement.
She then delivers strategic input to the Clinical Development Plan to minimise the risk of a negative or restricted reimbursement outcome.
When working with Eimear, you will deal with a highly conscientious professional who is practical, down-to-earth and friendly.
Nic Lochlainn Consulting delivers work within agreed timeframes to meet both internal and external timelines.
K Sparrowhawk, Partner
...exceptional expertise...She has a can-do attitude, delivers quality work and is an absolute pleasure to work with.